3rd Vienna Breast Surgery Day

Dear colleagues,
Programme
The 3rd Vienna Breast Surgery Day focuses on two
main topics: ductal carcinoma in situ (DCIS) and
the operation of stage-IV tumours. 30 percent of all
breast operations are due to DCIS, and the mastectomy rates are even higher than those with invasive
carcinoma.
8.00 a.m.
The word “carcinoma” in DCIS gives many women
an unnecessary shock. Because DCIS does not
cause metastases and can be cured, many experts
would like to rename the disease. In addition to
finding a less frightening term for DCIS, we should
consider whether women are being over-treated
and rethink our therapy approach.
Research data appear inconclusive about whether
surgery is necessary for stage-IV tumours. We will
discuss new prospective data coming from Canada, US,
and Europe, to help us determine future treatment.
Comprehensive Cancer Center Vienna
We will discuss these topics with internationally renowned experts and speakers, who are also speaking at the St. Gallen Breast Cancer Conference.
WeMEDUNI
look forward
to welcoming you to the 3rd Vienna
EINE EINRICHTUNG VON
WIEN
UND AKH WIEN
Breast Surgery Day.
Invitation
3rd Vienna
Breast Surgery Day
Local therapy: DCIS and Stage IV
Yours sincerely,
Florian Fitzal and Michael Gnant, Breast Health
Center, Medical University of Vienna / Vienna
General Hospital, Comprehensive Cancer Center
Vienna
Farid Moinfar, Hospital of the Sisters of Charity,
Linz, Austria
Admission
8.00 – 8.40 a.m.
Registration and Viennese Breakfast
8.40 – 8.45 a.m.
Welcome address
Christoph Zielinski, Medical University of Vienna / Vienna General Hospital, Austria
Is DCIS a true cancer? Long term outcome
W. Fraser Symmans, University of Texas, USA
Subtyping DCIS: from VNPI to genomic tests
Giuseppe Curigliano, European Institute of
Oncology, Milan, Italy
10.15 – 10.30 a.m.
Coffee break I
10.30 – 11.15 a.m.
9.00 – 10.15 a.m.
Session 1
Is DCIS a true cancer?
Chair: Fattaneh A. Tavassoli, Yale University
Medical School, New Haven, USA
Giuseppe Viale, University of Milan, Italy
Ductal intraepithelial neoplasia
Farid Moinfar, Hospital of the Sisters of Charity,
Linz, Austria
11.15 – 11.30 a.m.
VBSD Life Time achievement award 2017
Faculty discussion: Terminology
Fattaneh A. Tavassoli, Yale University Medical
School, New Haven, USA
Michael Gnant, Medical University of Vienna / Vienna General Hospital, Austria
Oreste Davide Gentilini, European Institute of
Oncology, Milan, Italy
Giuseppe Viale, University of Milan, Italy
8.45 – 9.00 a.m.
Presentation of the faculty board
Florian Fitzal, Medical University of Vienna / Vienna
General Hospital, Austria
Contralateral mastectomy: hype or hope
Tari King, Memorial Sloan-Kettering CC in
Manhattan, New York, USA
Session 2
Treatment of DCIS: Surgical considerations
Chair: Monica Morrow, Memorial Sloan-Kettering
CC in Manhattan, New York, USA
Raimund Jakesz, Medical University of Vienna / Vienna General Hospital, Austria
11.30 a.m. – 12.00 p.m.
Session 3
Treatment of DCIS: Radiooncologic view
Chair: Roberto Orecchia, European Institute of
Oncology, Milano, Italy
Felix Sedlmayer, University Clinic Salzburg,
Austria
Guided Radiotherapy not for all DCIS
Boon Chua, Breast Cancer Institute Melbourne,
Australia
Radiotherapy for all DCIS patients
Felix Sedlmayer, University Hospital Salzburg,
Austria
12.00 – 1.00 p.m.
Lunch break
DCIS and resection margins
Monica Morrow, Memorial Sloan-Kettering CC in
Manhattan, New York, USA
March 14th, 2017
Medical University of Vienna, Van Swieten Saal,
Van-Swieten-Gasse 1a, 1090 Vienna, Austria
Comprehensive Cancer Center Vienna
www.ccc.ac.at
EINE EINRICH
UND AKH WIEN
1.00 – 1.30 p.m.
2.15 – 3.15 p.m.
3.45 – 4.00 p.m.
Session 4
Session 5
Coffee break III
Diagnosis of DCIS
Chair: Christian Singer, Medical University of
Vienna / Vienna General Hospital, Austria
Tari King, Memorial Sloan-Kettering CC in
Manhattan, New York, USA
Treatment of DCIS: systemic therapy
Chair: Günther Steger, Medical University of
Vienna / Vienna General Hospital, Austria
Giuseppe Courigliano, European Institute of
Oncology, Milano, Italy
Endocrine therapy for all Er+
Jack Cuzick, Queen Mary Institute, London, UK
MR is important for diagnosis
Thomas Helbich, Medical University of Vienna / Vienna General Hospital, Austria
MR does not help for surgical decision
Monica Morrow, Memorial Sloan-Kettering CC in
Manhattan, New York, USA
1.30 – 2.00 p.m.
Faculty Discussion: Optimal local treatment
Monica Morrow, Memorial Sloan-Kettering CC in
Manhattan, New York, USA
Michael Gnant, Medical University of Vienna / Vienna General Hospital, Austria
Roberto Orrechia, European Institute of
Oncology, Milan, Italy
Felix Sedlmayer, Paracelsus Medical University,
Salzburg, Austria
2.00 – 2.15 p.m.
Coffee break II
No endocrine therapy at all
Christian Singer, Medical University of Vienna / Vienna General Hospital, Austria
Risk stratified systemic treatment
Oreste Davide Gentilini, European Institute of
Oncology, Milan, Italy
Is lifestyle change important for prophylaxis?
Pamela Goodwin, University of Toronto, Canada
3.15 – 3.45 p.m.
Faculty Discussion: Optimal systemic treatment
Günther Steger, Medical University of Vienna / Vienna General Hospital, Austria
Giuseppe Curigliano, European Institute of
Oncology, Milan, Italy
Farid Moinfar, Hospital of the Sisters of Charity,
Linz, Austria
Rupert Bartsch, Medical University of Vienna / Vienna General Hospital, Austria
4.00 – 4.15 p.m.
Session 6
Surgery of the primary in stage IV
Chair: Peter Dubsky, Klinik St. Anna, Luzern,
Switzerland
Surgery in stage IV: Hype or Hope
Florian Fitzal, Medical University of Vienna / Vienna General Hospital, Austria
4.15 – 4.30 p.m.
Faculty discussion: optimal local therapy in stage IV
Peter Dubsky, Klinik St. Anna, Luzern, Switzerland
Günther Steger, Medical University of Vienna / Vienna General Hospital, Austria
Michael Knauer, Kantonsspital St. Gallen,
Switzerland
Tari King, Memorial Sloan-Kettering CC in
Manhattan, New York, USA
4.30 – 5.10 p.m.
Session 7
Incisions for SSM/NSM and safety data
Florian Fitzal, Medical University of Vienna / Vienna
General Hospital, Austria
Reconstruction – How I do it
Peter Schrenk, Johannes Kepler University Linz,
Austria
Reconstruction – How I do it
Rupert Koller, Wilhelminenspital Vienna, Austria
Reconstruction – How I do it
Klaus Schrögendorfer, Medical University of
Vienna / Vienna General Hospital, Austria
Reconstruction – How I do it
Jian Farhadi, Guy’s and St Thomas’ Hospital,
London, UK
Closing Remarks
Registration
[email protected]
Space is limited to 100 participants and therefore
registration is required. Please note that registration is only valid after the conference fees have
been received.
Congress fee: 220 Euro
Account data:
Medizinische Universität Wien
IBAN-Code: AT362011140410070700
BIC-Code: GIBAATWW
Payment reference: KO71500002
Organization
Florian Fitzal, Breast Health Center, Medical
University of Vienna / Vienna General Hospital,
Austria
Michael Gnant, Breast Health Center, Medical
University of Vienna / Vienna General Hospital,
Austria
Farid Moinfar, Hospital of the Sisters of Charity,
Linz, Austria
Co-operation
Mastectomy and Reconstruction: How I do it
Chair: Michael Knauer, Kantonsspital St. Gallen,
Switzerland
Christian Singer, Medical University of Vienna / Vienna General Hospital, Austria
Comprehensive Cancer Center Vienna
EINE EINRICH
UND AKH WIE

Download Report